Pyxis Oncology Inc. Common Stock is a leading biotechnology company that specializes in developing innovative immunotherapies for the treatment of cancer. With a focus on harnessing the power of the immune system, Pyxis is dedicated to transforming the landscape of cancer care and improving patient outcomes.
